GREM1 and neoplasm: Some well‐studied BMP antagonists include Noggin, which has been implicated in promoting skin and breast cancer tumorigenesis, and the Gremlins (GREM1 and 2), with repression of GREM1 shown to inhibit tumour cell proliferation.